Center for Scientific Review; Notice of Meeting, 10236 [07-1032]

Download as PDF 10236 Federal Register / Vol. 72, No. 44 / Wednesday, March 7, 2007 / Notices (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.844, 93.846–93.878, 93.892, National Institutes of Health, HHS) Dated: February 28, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1030 Filed 3–6–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Institutes of Health Peer Review Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: National Institutes of Health Peer Review Advisory Committee. Date: April 19, 2007. Time: 8:30 a.m. to 5 p.m. Agenda: Provide technical and scientific advice to the Director, National Institutes of Health (NIH), the Deputy Director for Extramural Research, NIH and the Director, Center for Scientific Review (CSR), on matters relating broadly to review procedures and policies for the evaluation of scientific and technical merit of applications for grants and awards. Place: National Institutes of Health, Natcher Building, 45 Center Drive, Rooms E1–E2, Bethesda, MD 20892. Contact Person: Cheryl A. Kitt, PhD, Executive Secretary, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3030, MSC 7776, Bethesda, MD 20892, 301–435–1112, kittc@csr.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has instituted strigent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 28, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1032 Filed 3–6–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Name of Committee: Center for Scientific Review Special Emphasis Panel, Semescence and Stem Cells. Date: March 10, 2007. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: James Harwood, PhD, Scientific Review Administrator, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5168, MSC 7840, Bethesda, MD 20892, 301–435– 1256, harwoodj@csr.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 28, 2007. Anna Snouffer, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–1034 Filed 3–6–07; 8:45 am] BILLING CODE 4140–01–M National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. DEPARTMENT OF HOMELAND SECURITY Bureau of Customs and Border Protection Notice of Cancellation of Customs Broker Permit Bureau of Customs and Border Protection, U.S. Department of Homeland Security. AGENCY: ACTION: General Notice. SUMMARY: Pursuant to section 641 of the Tariff Act of 1930, as amended, (19 U.S.C. 1641) and the Customs Regulations (19 CFR 11 1.51), the following Customs broker permits are cancelled without prejudice. sroberts on PROD1PC70 with NOTICES Name Permit No. HYC Logistics, Inc. .......................................................................................................................................... Braverman Enterprises, Inc. ........................................................................................................................... Martin, Kassatly & Company .......................................................................................................................... Cornerstone Logistics, Inc. ............................................................................................................................. Alfredo Mesa ................................................................................................................................................... BLG, Inc. ......................................................................................................................................................... Gallagher Transport International, Inc. ........................................................................................................... Exel Global Logistics, Inc. ............................................................................................................................... Exel Global Logistics, Inc. ............................................................................................................................... Exel Global Logistics, Inc. ............................................................................................................................... Exel Global Logistics, Inc. ............................................................................................................................... David II Kim Dba ACE American Express ...................................................................................................... Charter Brokerage Corp. ................................................................................................................................. 28–05–E69 200113 13056–P 17392–P 52–04–B IC 081 0158 3501–01–0063 5398–001 26–01–006 4979–P 94014 53–03–U14 VerDate Aug<31>2005 18:25 Mar 06, 2007 Jkt 211001 PO 00000 Frm 00125 Fmt 4703 Sfmt 4703 E:\FR\FM\07MRN1.SGM 07MRN1 Issuing Port San Francisco. Los Angeles. San Francisco. San Francisco. Miami. New York. St. Louis. Minneapolis. Houston. Nogales. San Francisco. Los Angeles. Houston.

Agencies

[Federal Register Volume 72, Number 44 (Wednesday, March 7, 2007)]
[Notices]
[Page 10236]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-1032]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of 
the National Institutes of Health Peer Review Advisory Committee.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: National Institutes of Health Peer Review 
Advisory Committee.
    Date: April 19, 2007.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: Provide technical and scientific advice to the Director, 
National Institutes of Health (NIH), the Deputy Director for 
Extramural Research, NIH and the Director, Center for Scientific 
Review (CSR), on matters relating broadly to review procedures and 
policies for the evaluation of scientific and technical merit of 
applications for grants and awards.
    Place: National Institutes of Health, Natcher Building, 45 
Center Drive, Rooms E1-E2, Bethesda, MD 20892.
    Contact Person: Cheryl A. Kitt, PhD, Executive Secretary, Center 
for Scientific Review, National Institutes of Health, 6701 Rockledge 
Drive, Room 3030, MSC 7776, Bethesda, MD 20892, 301-435-1112, 
kittc@csr.nih.gov.
    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    In the interest of security, NIH has instituted strigent 
procedures for entrance onto the NIH campus. All visitor vehicles, 
including taxicabs, hotel, and airport shuttles will be inspected 
before being allowed on campus. Visitors will be asked to show one 
form of identification (for example, a government-issued photo ID, 
driver's license, or passport) and to state the purpose of their 
visit.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 28, 2007.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-1032 Filed 3-6-07; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.